Cocrystal Pharma Inc (COCP)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$1.00-0.99%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · COCP
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Revenues | — | — | — | — | — | — | 2.0 | 6.6 |
| Operating Expenses & Income | ||||||||
| R&D Expenses | 6.1 | 5.1 | 12.5 | 15.2 | 12.4 | 8.8 | 6.0 | 4.0 |
| Operating Income | (10.1) | (9.0) | (17.9) | (18.6) | (38.8) | (14.2) | (9.6) | (48.4) |
| Earnings from Continuing Operations | ||||||||
| Interest Expense | — | (0.1) | (0.5) | (0.6) | 0.0 | 0.0 | 0.0 | 0.1 |
| Other Non-Operating Income / Expenses | 0.2 | 0.2 | 0.4 | 0.6 | (0.0) | 0.0 | (0.1) | 0.2 |
| Asset Writedown | — | — | — | — | 19.1 | — | — | 46.1 |
| EBT, Incl. Unusual Items | — | (8.8) | — | — | — | — | (9.6) | (48.2) |
| Income Tax Expense | — | — | — | — | — | — | — | (13.6) |
| Net Income | ||||||||
| Net Income | (9.9) | (8.8) | (17.5) | (18.0) | (38.8) | (14.2) | (9.6) | (48.2) |
| Per Share | ||||||||
| Basic EPS | (0.72) | (0.78) | (1.72) | (1.87) | (4.77) | (0.16) | — | — |
| Diluted EPS | (0.72) | (0.78) | (1.72) | (1.87) | (4.77) | — | — | — |
| Basic Weighted Avg Shares | 13.8 | 11.3 | 10.2 | 9.7 | 8.1 | 7.4 | — | 0.0 |
| Diluted Weighted Avg Shares | 13.8 | 11.3 | 10.2 | 9.7 | 8.1 | — | — | — |
| Supplemental | ||||||||
| EBITDA | — | (8.9) | (17.8) | (18.4) | (38.6) | (14.0) | (9.4) | (48.3) |
| EBIT | (10.1) | (9.0) | (17.9) | (18.6) | (38.8) | (14.2) | (9.6) | (48.4) |
| Effective Tax Rate | — | — | — | — | — | — | — | 28.2% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.